93 related articles for article (PubMed ID: 15567947)
1. [P63 protein in the diagnosis of breast tubular carcinoma].
Noël JC; Fayt I; Fernandez-Aguilar S
Ann Pathol; 2004 Sep; 24(4):319-23. PubMed ID: 15567947
[TBL] [Abstract][Full Text] [Related]
2. p63 and CD10: reliable markers in discriminating benign sclerosing lesions from tubular carcinoma of the breast?
de Moraes Schenka NG; Schenka AA; de Souza Queiroz L; de Almeida Matsura M; Alvarenga M; Vassallo J
Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):71-7. PubMed ID: 16540734
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
Werling RW; Hwang H; Yaziji H; Gown AM
Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930
[TBL] [Abstract][Full Text] [Related]
4. p63 Staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast.
Reis-Filho JS; Milanezi F; Amendoeira I; Albergaria A; Schmitt FC
J Clin Pathol; 2002 Dec; 55(12):936-9. PubMed ID: 12461063
[TBL] [Abstract][Full Text] [Related]
5. Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast: an analysis of 82 samples.
Reis-Filho JS; Milanezi F; Amendoeira I; Albergaria A; Schmitt FC
Cancer; 2003 Jun; 99(3):172-9. PubMed ID: 12811858
[TBL] [Abstract][Full Text] [Related]
6. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast.
Barbareschi M; Pecciarini L; Cangi MG; Macrì E; Rizzo A; Viale G; Doglioni C
Am J Surg Pathol; 2001 Aug; 25(8):1054-60. PubMed ID: 11474290
[TBL] [Abstract][Full Text] [Related]
7. Myoepithelial cell cocktail (p63+SMA) for the evaluation of sclerosing breast lesions.
Pavlakis K; Zoubouli C; Liakakos T; Messini I; Keramopoullos A; Athanassiadou S; Kafousi M; Stathopoulos EN
Breast; 2006 Dec; 15(6):705-12. PubMed ID: 16384708
[TBL] [Abstract][Full Text] [Related]
8. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
9. p63 expression in benign and malignant breast lesions.
Stefanou D; Batistatou A; Nonni A; Arkoumani E; Agnantis NJ
Histol Histopathol; 2004 Apr; 19(2):465-71. PubMed ID: 15024707
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of maspin is a useful adjunct in distinguishing radial sclerosing lesion from tubular carcinoma of the breast.
Lele SM; Graves K; Gatalica Z
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):32-6. PubMed ID: 10937046
[TBL] [Abstract][Full Text] [Related]
11. p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis.
Parsons JK; Gage WR; Nelson WG; De Marzo AM
Urology; 2001 Oct; 58(4):619-24. PubMed ID: 11597556
[TBL] [Abstract][Full Text] [Related]
12. p63 is useful in the diagnosis of mammary metaplastic carcinomas.
Tse GM; Tan PH; Chaiwun B; Putti TC; Lui PC; Tsang AK; Wong FC; Lo AW
Pathology; 2006 Feb; 38(1):16-20. PubMed ID: 16484002
[TBL] [Abstract][Full Text] [Related]
13. Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation.
Bratthauer GL; Saenger JS; Strauss BL
Histopathology; 2005 Dec; 47(6):611-6. PubMed ID: 16324199
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.
Shah RB; Zhou M; LeBlanc M; Snyder M; Rubin MA
Am J Surg Pathol; 2002 Sep; 26(9):1161-8. PubMed ID: 12218572
[TBL] [Abstract][Full Text] [Related]
15. p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma.
Koker MM; Kleer CG
Am J Surg Pathol; 2004 Nov; 28(11):1506-12. PubMed ID: 15489655
[TBL] [Abstract][Full Text] [Related]
16. Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray.
Reis-Filho JS; Simpson PT; Martins A; Preto A; Gärtner F; Schmitt FC
Virchows Arch; 2003 Aug; 443(2):122-32. PubMed ID: 12884041
[TBL] [Abstract][Full Text] [Related]
17. p63: a novel myoepithelial cell marker in canine mammary tissues.
Gama A; Alves A; Gartner F; Schmitt F
Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
[TBL] [Abstract][Full Text] [Related]
18. p63 Expression of clear myoepithelial cells in epithelial-myoepithelial carcinoma of the salivary gland: a useful marker for naked myoepithelial cells in cytology.
Kawahara A; Harada H; Yokoyama T; Kage M
Cancer; 2005 Aug; 105(4):240-5. PubMed ID: 15959915
[TBL] [Abstract][Full Text] [Related]
19. Novel and classic myoepithelial/stem cell markers in metaplastic carcinomas of the breast.
Reis-Filho JS; Milanezi F; Paredes J; Silva P; Pereira EM; Maeda SA; de Carvalho LV; Schmitt FC
Appl Immunohistochem Mol Morphol; 2003 Mar; 11(1):1-8. PubMed ID: 12610349
[TBL] [Abstract][Full Text] [Related]
20. Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas.
Hill CB; Yeh IT
Am J Clin Pathol; 2005 Jan; 123(1):36-44. PubMed ID: 15762278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]